Align Technology Inc. ($ALGN) Stock Forecast: Down 5.9% Today

What is Align Technology Inc.?

Align Technology Inc. (ALGN) is a global medical device company specializing in the Invisalign system for malocclusion treatment, renowned for its cutting-edge digital orthodontic solutions.

Why is Align Technology Inc. going down?

ALGN stock is down 5.9% on Feb 13, 2026 15:16

• The bearish movement in ALGN stock today might be linked to profit-taking by institutional investors like Candriam S.C.A. and Savant Capital LLC, who have recently decreased their holdings in the company.
• Despite exceeding quarterly earnings and revenue expectations, market sentiments could be influenced by analysts' concerns regarding potential margin dilution from new technologies, surfaced during the Q4 earnings call.
• Ongoing legal disputes with Angelalign Technology Inc. concerning patent infringement and the uncertainty surrounding a preliminary European court ruling on software features could be exerting downward pressure on the stock.
• While the collaboration with the University of Bern for the Oral Health Study signals a promising avenue for market enlargement, investors could be exercising caution due to uncertainties about immediate sales impact and potential pricing challenges in public health programs.

ALGN Price Chart

ALGN Technical Analysis

ALGN News

Align’s Swiss Oral Health Study Puts Digital Tools And Growth Story To Test

Align Technology is collaborating with the University of Bern on Switzerland's first comprehensive Oral Health Study, utilizing Align's iTero Lumina digital scanners and mobile dental vans to collect real-time oral health data. This partnership aims to expand the use of Align's digital tools in public health, moving beyond its core orthodontic products and potentially reinforcing its market position against competitors. While the study could broaden Align's addressable market through new preventive care use cases, investors should consider the risk that it may not immediately translate into higher sales or could expose Align to pricing pressures in large-scale public health programs.

https://simplywall.st/stocks/us/healthcare/nasdaq-algn/align-technology/news/aligns-swiss-oral-health-study-puts-digital-tools-and-growth

Angelalign Technology Inc. (6699.HK) Says a Preliminary European Court Ruling on Certain Software Features Will Have Minimal Impact on Users

Angelalign Technology Inc. announced that a preliminary ruling by a German court regarding its software features for clear aligners will have minimal impact on its users. The company plans to launch an upgraded feature, iPlan, for affected European users and is challenging the patent infringement claims by Align Technology Inc. Angelalign denies any infringement and is confident the injunction will be overturned.

https://www.businesswire.com/news/home/20260212616683/en/Angelalign-Technology-Inc.-6699.HK-Says-a-Preliminary-European-Court-Ruling-on-Certain-Software-Features-Will-Have-Minimal-Impact-on-Users

Candriam S.C.A. Sells 9,163 Shares of Align Technology, Inc. $ALGN

Candriam S.C.A. reduced its stake in Align Technology (NASDAQ:ALGN) by 15.7%, selling 9,163 shares and retaining 49,263 shares valued at approximately $6.17 million. Despite mixed analyst ratings, with a consensus "Hold" and an average price target of $195.92, Align Technology recently surpassed quarterly earnings and revenue estimates. The company reported $3.29 EPS against an expected $2.99 and $1.05 billion in revenue against an estimated $1.03 billion, representing a 5.3% year-over-year revenue increase.

https://www.marketbeat.com/instant-alerts/filing-candriam-sca-sells-9163-shares-of-align-technology-inc-algn-2026-02-12/

5 Must-Read Analyst Questions From Align Technology's Q4 Earnings Call

Align Technology's Q4 earnings call highlighted strong growth in clear aligner volumes, particularly in international markets and within dental service organizations (DSOs), leading to a positive market response. Analysts focused on understanding the drivers of this volume growth, future guidance assumptions, average selling price trends, and the margin impact of direct fabrication. The company addressed these concerns by crediting market stability, successful execution in DSOs, and product innovation, while also acknowledging potential short-term margin dilution from new technologies.

https://finviz.com/news/307128/5-must-read-analyst-questions-from-align-technologys-q4-earnings-call

Savant Capital LLC Decreases Stock Holdings in Align Technology, Inc. $ALGN

Savant Capital LLC significantly reduced its stake in Align Technology (ALGN) by 60.4% in Q3, selling over 11,000 shares. Despite this, Align Technology surpassed quarterly earnings and revenue estimates, reporting strong year-over-year revenue growth. Institutional ownership of ALGN stock remains high at 88.43%, with analysts giving the stock an average "Hold" rating and a price target close to its current trading price.

https://www.marketbeat.com/instant-alerts/filing-savant-capital-llc-decreases-stock-holdings-in-align-technology-inc-algn-2026-02-11/

Trending Today

Align Technology Inc. Price History

31.06.2025 - ALGN Stock was down 35.7%

• ALGN stock saw a notable bearish movement today.
• The company's second-quarter earnings and revenue fell below expectations, prompting a significant drop in its stock price.
• Sales of Clear Aligners declined, and margins were squeezed, raising concerns among investors.
• Align's subdued guidance for the third quarter fueled the prevailing pessimism about the stock, leading to a decline of over 34%.

31.06.2025 - ALGN Stock was down 29.9%

• The stock of Align Technology dropped as the company failed to meet second-quarter earnings projections and offered a weaker third-quarter outlook, disappointing investors.
• Disappointing Q2 earnings and revenue numbers that fell below expectations from analysts added to the negative sentiment surrounding the stock.
• Despite the potential for growth from Invisalign and iTero upgrades, the market reacted strongly to the company's recent financial performance, resulting in a sharp decrease in ALGN's stock price.
• Today's bearish movement in ALGN underscores the market's attentiveness to earnings reports and future guidance, stressing the significance of meeting or surpassing investor expectations to uphold positive stock performance.

06.01.2026 - ALGN Stock was up 5.1%

• A higher price target of $220 set by Piper Sandler for Align Technology post a robust Q4 showing, with revenue reaching $1.048 billion and $3.29 EPS, has bolstered investor confidence, resulting in a positive trend in the stock.
• Record revenue achieved by the company in Q4 and fiscal 2025, attributed to a significant increase in Clear Aligner case volumes worldwide, signals its strong market position and growth prospects, further elevating investor optimism.
• Despite negative earnings forecasts, Align Technology's strong performance and favorable 2026 outlook demonstrate its adept navigation of challenges and effective capitalization on market opportunities, contributing to the upward momentum in the market.

13.01.2026 - ALGN Stock was down 5.9%

• The bearish movement in ALGN stock today might be linked to profit-taking by institutional investors like Candriam S.C.A. and Savant Capital LLC, who have recently decreased their holdings in the company.
• Despite exceeding quarterly earnings and revenue expectations, market sentiments could be influenced by analysts' concerns regarding potential margin dilution from new technologies, surfaced during the Q4 earnings call.
• Ongoing legal disputes with Angelalign Technology Inc. concerning patent infringement and the uncertainty surrounding a preliminary European court ruling on software features could be exerting downward pressure on the stock.
• While the collaboration with the University of Bern for the Oral Health Study signals a promising avenue for market enlargement, investors could be exercising caution due to uncertainties about immediate sales impact and potential pricing challenges in public health programs.

01.07.2025 - ALGN Stock was up 5.3%

• Despite recent challenges with missed earnings and revenue estimates, ALGN witnessed a notable positive movement in the market today.
• The surge in market sentiment could be linked to significant investors showing a strong positive outlook on Align Technology, evident from the rise in options trading activities.
• The stock's technical position, which was previously considered oversold, along with potential signals of a reversal in trends resulting from analysts upgrading earnings estimates, likely fueled the positive momentum.
• Investors seem to perceive the recent decline in ALGN stock price as an attractive buying opportunity, particularly following the substantial decrease post the Q2 earnings miss, revenue shortfall, and margin tightening.

03.11.2025 - ALGN Stock was up 5.1%

• ALGN experienced a strong bullish movement today, driven by several positive developments:
• The launch of new aligner options and direct fabrication technology is expected to drive growth and margin gains for the company.
• Expansion into new markets like South Africa and the Philippines with innovative digital dentistry solutions is enhancing ALGN's global presence.
• The company's focus on digital innovation, patient engagement, and personalized treatment journeys is resonating well with practitioners and patients alike.
• Despite a recent share price jump and positive news flow, there is still a debate about the stock's valuation, with some suggesting it may be undervalued due to expanding clinical indications and increased adoption by dentists.

12.01.2026 - ALGN Stock was down 5.1%

• ALGN surpassed earnings and revenue projections for the quarter but faced a downward trend in the market.
• Reductions in ownership stakes by institutional investors like Candriam S.C.A. and Savant Capital LLC may have influenced the negative market sentiment towards ALGN.
• Analysts' scrutiny of average selling prices and potential profit dilution from new technologies during the earnings briefing likely sparked concerns among investors, impacting the stock's performance.
• Despite the current market pessimism, the optimistic forecast for growth in the global dental impression systems market, attributed to technological progress and rising demand, could signify a favorable long-term outlook for ALGN.

05.01.2026 - ALGN Stock was up 10.2%

• The company reported better-than-expected Q4 2025 earnings and revenue, with record revenues and clear aligner volumes, leading to a significant surge in its stock price.
• Despite the company's gross and operating margins contracting due to increased costs and expenses, investors were still impressed by the overall performance and outlook for 2026 revenue growth.
• The positive outlook for the company, driven by strategic priorities like international expansion and increased orthodontic utilization, contributed to the bullish sentiment surrounding ALGN stock.
• The market's enthusiastic response to the earnings report and optimistic projections reflects investors' confidence in the company's growth potential and ability to navigate the dynamic macro environment.

13.07.2025 - ALGN Stock was up 5.8%

• Despite a less optimistic growth forecast, the CEO's confidence in ALGN's undervalued shares could have positively influenced investor sentiment.
• The rise in ALGN's stock price may indicate investor confidence in the company's future potential and the CEO's belief in its undervaluation.
• This upward movement could imply that investors are looking beyond immediate hurdles, focusing on the company's innovation and market dominance in the long term.

03.01.2026 - ALGN Stock was down 5.2%

• The stock of Align Technology (ALGN) recently saw a significant decrease, potentially influenced by various factors:
• Historical patterns of missing revenue estimates in previous quarters may have caused investor uncertainty and selling pressure, despite the current expectations of revenue growth and earnings per share.
• A partnership with the University of Bern for a notable epidemiological study on oral health trends in Switzerland, though enhancing the company's reputation, may not have yielded immediate benefits to bolster investor confidence.
• Efforts to support healthcare research and initiatives, although laudable, might not have directly translated into immediate financial gains, contributing to a negative investor outlook.
• General market conditions and sector-specific influences could have also affected ALGN stock's decline, as overall market trends can impact individual stock performance.

30.09.2025 - ALGN Stock was up 10.1%

• ALGN experienced a significant increase in its stock price today following the release of its Q3 earnings, which exceeded both earnings and revenue projections.
• The earnings surpassed expectations by +10.13% and revenue by +2.49%, highlighting the company's robust financial performance and strong market demand for its products.
• Investor sentiment appears positive regarding ALGN's future growth potential, driven by its innovative dental solutions and leading position in clear aligner technology.
• The outperformance in financial results suggests that ALGN is effectively leveraging the growing interest in orthodontic treatments, establishing a favorable position for its stock in the market.

30.09.2025 - ALGN Stock was up 5.4%

• ALGN stock notably surged in today's trading.
• The remarkable Q3 earnings and revenue exceeded expectations by a substantial margin, bolstering market confidence.
• However, despite the positive financial results, investors may have been unsettled by the considerable decrease in margins, potentially affecting the stock's performance.
• Investors are keenly observing upcoming developments to evaluate Align Technology's ability to sustain its growth momentum while addressing margin concerns.